Catalent (CTLT) Tops Q2 EPS by 8c, Revenues Beat; Offers FY19 Revenue Mid-Point Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. LVS
7. SAP
8. CSX
9. LRCX
10. MRK

Go back to Catalent (CTLT) Tops Q2 EPS by 8c, Revenues Beat; Offers FY19 Revenue Mid-Point Guidance Above Consensus

Catalent, Inc. Reports Second Quarter Fiscal 2019 Results

February 5, 2019 7:30 AM EST

Q2'19 revenue of $623.0 million increased 3% as-reported, or 5% in constant currency, from the prior-year period. Q2'19 YTD revenue of $1,174.8 million increased 2% as-reported, or 4% in constant currency, from the prior-year period. Double-digit organic segment EBITDA growth within Biologics and Specialty Drug Delivery and Clinical Supply Services segments; Juniper acquisition continues to out-perform internal expectations. FY'19 financial guidance reaffirmed.

SOMERSET, N.J.--(BUSINESS WIRE)-- Catalent, Inc. (NYSE: CTLT), the... More